Literature DB >> 17955397

[Geriatric rehabilitation from the perspective of Book 9 of the German social code, SGB IX].

H Fuchs1.   

Abstract

The legal foundations for provision and realization of geriatric rehabilitation benefits are contained in particular in Book 9 of the German social code, SGB IX (covering rehabilitation and participation of people with disabilities). This paper discusses claims foundations and benefit prerequisites of geriatric rehabilitation taking into consideration the relations between Book 5 (on health insurance) and Book 9 of the social code. The article includes a definition of "geriatric rehabilitation" in light of the SGB IX, describes the benefit carriers' obligations as well as the procedure in place for determining geriatric rehab need, in this context appraising the designation as "geriatric patient" in terms of its appropriateness as an identifying criterion in determining need. Provision of geriatric rehab benefits is contingent on a potential for attaining rehab goals as specified by SGB IX as well as on fulfillment of the benefit prerequisites. Responsibility for the content, extent and quality of geriatric rehabilitation lies with the benefit carriers, as is the case for the obligation to secure availability of the required numbers and quality of rehabilitation facilities and services. The article specifies the legal foundations of the various benefit types (ambulatory, mobile rehab, under a Personal Budget, integrated benefit provision, or early rehab), and discusses geriatric rehabilitation in the framework of an insurance-based medical care system as well as of activating care.

Entities:  

Mesh:

Year:  2007        PMID: 17955397     DOI: 10.1055/s-2007-991135

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  1 in total

1.  [German version of the de Morton mobility index. First clinical results from the process of the cross-cultural adaptation].

Authors:  T Braun; R-J Schulz; M Hoffmann; J Reinke; L Tofaute; C Urner; H Krämer; T Bock; N de Morton; C Grüneberg
Journal:  Z Gerontol Geriatr       Date:  2015-02       Impact factor: 1.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.